Trademarkia Logo

Canada

C$
CylembIO (stylized)
SEARCHED

on 28 Jan 2025

Last Applicant/ Owned by

IO Biotech ApS

Ole Maaløes Vej 32200 Copenhagen N,

DK

Serial Number

2313920 filed on 6th Mar 2024

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

CylembIO (stylized)

Trademark usage description

pharmaceutical preparations; drugs; pharmaceutical substances; peptides for pharmaceutical use; vaccines.

Vienna Information


24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 2

DotsPoints

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

Classification Information


Class [005]
Pharmaceutical preparations; drugs; pharmaceutical substances; peptides for pharmaceutical use; vaccines.


Classification kind code

12

Mark Details


Serial Number

2313920

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 28th Jan 2025
Search Recorded
Submitted for opposition 20
on 28th Jan 2025
Examiner's First Report
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 287
on 21st Mar 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 6th Mar 2024
Filed
Submitted for opposition 1
on 6th Mar 2024
Created
Submitted for opposition 31
on 6th Mar 2024
Formalized